Mystic Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Sell
2,752
-52
-2% -$4.2K 0.05% 219
2026
Q1
$243K Hold
2,804
– – 0.06% 208
2025
Q4
$269K Sell
2,804
-309
-10% -$30K 0.06% 198
2025
Q3
$296K Hold
3,113
– – 0.07% 193
2025
Q2
$271K Sell
3,113
-31
-1% -$2.63K 0.07% 201
2025
Q1
$283K Sell
3,144
-100
-3% -$8.95K 0.07% 191
2024
Q4
$259K Buy
+3,244
New +$281K 0.07% 194
2022
Q1
– Sell
-937
Closed -$96K – 302
2021
Q4
$96K Buy
+937
New +$109K 0.05% 204

Other funds holding MDT

Mystic Asset Management's MDT Position: Q2 2026 in Review

Mystic Asset Management reduced its Medtronic (MDT) stake by 1.9% in Q2 2026, selling an estimated $4.2K and leaving 2,752 shares worth $215K. The position accounts for 0.05% of the portfolio, ranked #219.

Mystic Asset Management first reported a position in MDT in Q4 2021 and has held it in 8 quarters since. The position peaked at $296K in Q3 2025. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Mystic Asset Management held 2,752 shares of Medtronic worth $215K as of Q2 2026.
  • Mystic Asset Management sold 52 Medtronic shares in Q2 2026, an estimated $4.2K.
  • Medtronic made up 0.05% of Mystic Asset Management's portfolio in Q2 2026, its #219 holding.
  • Mystic Asset Management first reported a position in Medtronic in Q4 2021 and has held it in 8 quarters since.
  • Mystic Asset Management's Medtronic position peaked at $296K in Q3 2025.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Mystic Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.